Uterine fibroid embolization: Measurement of health-related quality of life before and after therapy

Journal of Vascular and Interventional Radiology

Volumn 10, Issue 10, 1999, Pages 1293-1303

  Spies, James B ^a   Warren, Elisabeth H ^b   Mathias, Susan D ^b   Walsh, Sheila M ^a   Roth, Antoinette R ^c   Pentecost, Michael J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Lewin TAG Inc   (United States)

^c NONE

Author keywords

Fibroid; Uterine arteries, therapeutic blockade; Uterus, neoplasms

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BACKACHE; CLINICAL ARTICLE; FEMALE; HUMAN; MENSTRUATION DISORDER; MICTURITION DISORDER; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; UTERUS MYOMA;

EID: 0032761493     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(99)70235-6     Document Type: Article

References (16)

1. Ravina J, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346:671-672.
2. Ravina J, Bouret J, Cirary-Vigneron N, et al. Application of participate arterial embolization in the treatment of uterine fibromyomata. Bull Acad Natl Med 1997; 181:233-243.
3. Goodwin S, Vedantham S, McLucas B, Forno A, Perrella R. Preliminary experience with uterine artery embolization for uterine fibroids. JVIR 1997; 8:517-526.
4. Worthington-Kirsch R, Popky G, Hutchins F. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 1998; 208:625-629.
5. World Health Organization. World Health Constitution. In: Basic Documents, World Health Organization. Geneva: World Health Organization; 1948.
6. Spies J, Scialli A, Jha R, et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata. JVIR 1999; 10:1149-1157.
7. Orsini L, Salardi S, Pilu G, Bovicelli L, Cacciari E. Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology 1984; 153:113-116.
8. Stewart A, Ware J, eds. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University; 1992.
9. Guyatt GH, Jaeschke R, Feeny DH, Patrick. Measurements in clinical trials: choosing the right approach. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven; 1996:41-58.
10. Patrick D, Devo R. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27:8217-8232.
11. Ware JE. The SF-36 health survey. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven; 1996:337-345.
12. Ware JE. SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute; 1993.
13. Clarke A, Black N, Rowe P, Mott S, Howle K. Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study. Br J Obstet Gynaecol 1995; 102:611-620.
14. Carlson K, Miller B, Fowler F. The Maine Women's Health Study: I. outcomes of hysterectomy. Obstet Gynecol 1994; 83:556-565.
15. Carlson K, Miller B, Fowler F. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994; 83:566-572.
16. Dwyer N, Hutton J, Stirrat G. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. Br J Obstet Gynaecol 1993; 100:237-243.